.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Deloitte
McKesson
AstraZeneca
McKinsey
Boehringer Ingelheim
Accenture
Johnson and Johnson
Julphar
Cantor Fitzgerald

Generated: June 28, 2017

DrugPatentWatch Database Preview

REVONTO Drug Profile

« Back to Dashboard

Which patents cover Revonto, and when can generic versions of Revonto launch?

Revonto is a drug marketed by Us Worldmeds and is included in one NDA.

The generic ingredient in REVONTO is dantrolene sodium. There are five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.

Summary for Tradename: REVONTO

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list17
Patent Applications: see list2,023
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REVONTO at DailyMed

Pharmacology for Tradename: REVONTO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds
REVONTO
dantrolene sodium
INJECTABLE;INJECTION078378-001Jul 24, 2007APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Express Scripts
Julphar
Chubb
Deloitte
Cantor Fitzgerald
Teva
Mallinckrodt
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot